Targeting Trends Newsletter 02q4

Below are links to view the quarterly newsletter Targeting Trends. If you would like to be added to the mailing list, please complete the information on our contact page.


Newsletter Highlights

  • Custom Conjugations (page 2)
  • Abstracts from FENS (page 5)
  • Abstracts from IASP (page 5)
  • anti-SERT-SAP (page 7)

[fivecol_one]Page 1Page 2Page 3Page 4Page 5Page 6Page 7Page 8[/fivecol_one][fivecol_four_last]

Does 192-IgG-Saporin or 5,7-DHT kill cognitive functions in the rat? (continued on page 6)

Contributed by Jean-Christophe Cassel, PhD, Laboratoire de Neurosciences Cognitives et Comportementales, UMR 7521 Université Louis Pasteur/CNRS, Strasbourg, France & Institut für Experimentelle und Klinische Pharmakologie und Toxikologie der Universität Freiburg, Neuropharmakologisches Labor, Freiburg, Germany. Dr. Cassel and colleagues are the authors of four publications released this quarter using 192-Saporin.

Product information related to cover article: 192-IgG-SAP (Cat. #IT-01)

SP-SAP Efficacy Reported at IASP 10th World Congress on Pain

Targeting Talk: Custom Antibody-Saporin conjugates

  • How do I know my antibody will work in an immunotoxin?
  • How much antibody do I need to provide for a custom conjugation?
  • How much of the saporin conjugate will that give me?
  • What is the ratio of saporin to antibody?
  • What quality control is involved? Will you provide product specifications such as average saporin to antibody ratio?
  • What is the cost of a custom immunotoxin preparation? How long will it take to complete?

Recent Scientific References

Abstracts from Forum of European Neuroscience (FENS): July 13-17, Paris France

Abstracts from IASP 10th World Congress on Pain: August 17-22, San Diego California

Does 192-IgG-Saporin or 5,7-DHT kill cognitive functions in the rat? (continued from page 1)

Targeting Teaser Winners

Targeting Tools: Anti-Tac and Anti-Tac-SAP

Targeting Technology Tutorial

Targeting Teaser (Jumble)

[/fivecol_four_last]